The contributions of T‐cell anergy to peripheral T‐cell tolerance

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Immunology

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2567.2001.01250.xPMID 11454055PMCID PMC1783252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE ROLE OF THE ALLOGRAFT IN THE INDUCTION OF DONOR-SPECIFIC T CELL HYPORESPONSIVENESS

  2001cited by this paper
• The role of T-cell anergy in the maintenance of donor-specific hyporesponsiveness in renal transplant recipients.

  2001cited by this paper
• PEPTIDE ANALOGUES AS A STRATEGY TO INDUCE TOLERANCE IN T CELLS WITH INDIRECT ALLOSPECIFICITY1

  2000cited by this paper
• The third function of the thymus.

  2000cited by this paper
• Induction of T Cell Anergy in the Absence of

  2000cited by this paper
• Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen Nonspecific

  2000cited by this paper
• Anergic T Cells Inhibit the Antigen-Presenting Function of Dendritic Cells1

  2000cited by this paper
• Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation

  2000cited by this paper
• Regulatory T cells: key controllers of immunologic self-tolerance.

  2000cited by this paper
• Induction of T Cell Anergy in the Absence of CTLA-4/B7 Interaction1

  2000cited by this paper
• Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells.

  1999cited by this paper
• Transplantation of anergic histoincompatible bone marrow allografts.

  1999cited by this paper
• Anergic T cells act as suppressor cells in vitro and in vivo

  1999cited by this paper
• CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.

  1999cited by this paper
• An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation

  1999cited by this paper
• Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.

  1999cited by this paper
• The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.

  1999cited by this paper
• Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans.

  1998cited by this paper
• Differences between responses of naive and activated T cells to anergy induction.

  1998cited by this paper
• Interferon-γ-treated renal tubular epithelial cells induce allospecific tolerance

  1998cited by this paper
• Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance.

  1998cited by this paper
• CTLA-4 regulates tolerance induction and T cell differentiation in vivo.

  1998cited by this paper
• Interleukin 10 Secretion and Impaired Effector Function of Major Histocompatibility Complex Class II–restricted T Cells Anergized In Vivo

  1998cited by this paper
• Interferon-gamma-treated renal tubular epithelial cells induce allospecific tolerance.

  1998cited by this paper
• Molecular basis of T cell inactivation by CTLA-4.

  1998cited by this paper
• CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.

  1998cited by this paper
• A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

  1997cited by this paper
• Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

  1997cited by this paper
• Anergic T cells effect linked suppression

  1997cited by this paper
• Dissociation of T cell anergy from apoptosis by blockade of Fas/Apo-1 (CD95) signaling.

  1997cited by this paper
• Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4+ T cells in vitro.

  1997cited by this paper
• Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells.

  1997cited by this paper
• Conditions That Induce Tolerance in Mature CD4+ T Cells

  1997cited by this paper
• T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases.

  1996cited by this paper
• Detection of donor-specific hyporesponsiveness following late failure of human renal allografts.

  1996cited by this paper
• Models of T cell anergy: is there a common molecular mechanism?

  1996cited by this paper
• Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

  1996cited by this paper
• Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals.

  1996cited by this paper
• Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

  1995cited by this paper
• Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance.

  1995cited by this paper
• Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

  1995cited by this paper
• CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

  1995cited by this paper
• Anergic T cells act as suppressor cells in vitro.

  1995cited by this paper
• Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance

  1995cited by this paper
• Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

  1995cited by this paper
• Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists

  1995cited by this paper
• Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy.

  1994cited by this paper
• Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire

  1994cited by this paper
• Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

  1994cited by this paper
• Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

  1994cited by this paper
• Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy

  1994cited by this paper
• CTLA-4 can function as a negative regulator of T cell activation.

  1994cited by this paper
• Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

  1994cited by this paper
• Anergic T cells as suppressor cells in vitro.

  1994cited by this paper
• Tolerance, danger, and the extended family.

  1994cited by this paper
• Th2 cell clonal anergy as a consequence of partial activation

  1994cited by this paper
• B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance

  1993cited by this paper
• Activation and differentiation requirements of primary T cells in vitro.

  1993cited by this paper
• Tolerance induction of human CD4+ T cells: markedly enhanced sensitivity of memory versus naive T cells to peripheral anergy.

  1993cited by this paper
• The B7 adhesion molecule is expressed on activated human T cells: Functional involvement in T‐T cell interactions

  1993cited by this paper
• Functional expression of B7/BB1 on activated T lymphocytes

  1993cited by this paper
• Multiple levels of peripheral tolerance.

  1993cited by this paper
• Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells

  1993cited by this paper
• Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling

  1993cited by this paper
• T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides

  1993cited by this paper
• B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro

  1993cited by this paper
• Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells

  1992cited by this paper
• Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor.

  1992cited by this paper
• Reversal of in vitro T cell clonal anergy by IL-2 stimulation.

  1992cited by this paper
• Monoclonal antibodies as agents to reinduce tolerance in autoimmunity.

  1992cited by this paper
• Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen.

  1992cited by this paper
• Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.

  1991cited by this paper
• Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production.

  1991cited by this paper
• Clonal anergy blocks the response to IL-4, as well as the production of IL-2, in dual-producing T helper cell clones.

  1991cited by this paper
• Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation.

  1991cited by this paper
• CTLA-4 is a second receptor for the B cell activation antigen B7

  1991cited by this paper
• Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

  1991cited by this paper
• Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice

  1990cited by this paper
• In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B

  1990cited by this paper
• B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.

  1989cited by this paper
• T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I–E

  1989cited by this paper
• Clonal anergy induced in mature Vβ6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells

  1989cited by this paper
• Co-internalization of the p55 and p70 subunits of the high-affinity human interleukin 2 receptor. Evidence for a stable ternary receptor complex

  1988cited by this paper
• Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness.

  1987cited by this paper
• Essential requirement for major histocompatibility complex recognition in T-cell tolerance induction

  1984cited by this paper
• Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin

  1983cited by this paper
• Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen.

  1980cited by this paper
• Isolation of a replication origin complex from Escherichia coli.

  1980cited by this paper

• Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy.

  2024cites this paper
• Intercellular transfer of MHC molecules in T cell alloimmunity and allotransplantation

  2024cites this paper
• Developing the POTOMAC Model: A Novel Prediction Model to Study the Impact of Lymphopenia Kinetics on Survival Outcomes in Head and Neck Cancer Via an Ensemble Tree-Based Machine Learning Approach

  2023cites this paper
• Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapy

  2022cites this paper
• PD1, CTLA4 and TIGIT Expression on T and NK Cells in Granulomatous Diseases: Sarcoidosis and ANCA-Associated Vasculitis

  2022cites this paper
• Saga of monokines in shaping tumour-immune microenvironment: Origin to execution.

  2022cites this paper
• T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen

  2022cites this paper
• Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis.

  2021cites this paper
• Zbtb10 transcription factor is crucial for murine cDC1 activation and cytokine secretion

  2021cites this paper
• Primary Biliary Cholangitis

  2021cites this paper
• The immune system in infants: Relevance to xenotransplantation

  2020cites this paper
• The Paradigm of T Cells in Shaping Tumor Microenvironment

  2020cites this paper
• Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease

  2019cites this paper
• Immune checkpoint failures in inflammatory myopathies: An overview.

  2018cites this paper
• Possible Critical Role of Latent Chronic Toxoplasma Gondii Infection in Triggering, Development and Persistence of Autoimmune Diseases

  2018cites this paper
• Antibody Therapeutic Prediction and Design: Immunogenicity and Stability

  2017cites this paper
• Image-Based Phenotypic Screening with Human Primary T Cells Using One-Dimensional Imaging Cytometry with Self-Tuning Statistical-Gating Algorithms

  2017cites this paper
• Immune tolerance induced by platelet‐targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated

  2017cites this paper
• 抗血小板GPⅠbα抗体诱导建立原发免疫性血小板减少症模型的研究

  2017cites this paper
• [A Study on the establishment of immune thrombocytopenia model induced by anti-platelet GPⅠbα antibodies].

  2017cites this paper
• Mannosylated lipopetides as model vaccines for targeting the mannose receptor

  2016cites this paper
• Factors influencing regulatory T cell maintenance for the control of autoimmunity

  2016cites this paper
• Effector, Memory, and Dysfunctional CD8+ T Cell Fates in the Antitumor Immune Response

  2016cites this paper
• Immature dendritic cells convert anergic nonregulatory T cells into Foxp3−IL‐10+ regulatory T cells by engaging CD28 and CTLA‐4

  2015cites this paper
• This information is current as by Activating Akt / mTOR Signaling Function of Human Double-Negative T Cells IL-7 Abrogates the Immunosuppressive

  2015cites this paper
• Evaluation of tumour vaccine immunotherapy for the treatment of advanced non-small cell lung cancer: a systematic meta-analysis

  2015cites this paper
• IL-7 Abrogates the Immunosuppressive Function of Human Double-Negative T Cells by Activating Akt/mTOR Signaling

  2015cites this paper
• Identification, caractérisation et validation de biomarqueurs liés à l’immunothérapie allergénique

  2015cites this paper
• The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis

  2015cites this paper
• Therapeutic induction of tolerance to reverse allergen-induced airway inflammation

  2015influential citation
• α-Galactosylceramide but Not Phenyl-Glycolipids Induced NKT Cell Anergy and IL-33–Mediated Myeloid-Derived Suppressor Cell Accumulation via Upregulation of egr2/3

  2014cites this paper
• The role of transitional B cells in kidney transplantation tolerance

  2014cites this paper
• Achievement of Transplantation Tolerance: Novel Approaches and Mechanistic Insights

  2014cites this paper
• This information is current as egr 2 / 3 Accumulation via Upregulation of Myeloid-Derived Suppressor Cell Mediated − Anergy and IL-33 Phenyl-Glycolipids Induced NKT Cell-Galactosylceramide but Not α

  2014cites this paper
• Therapeutic vaccines explored in patients with non-small cell lung cancer.

  2014cites this paper
• Efecto inmunomodulador de la vitamina d3 en la generación de células dendríticas e inhibidores de la glicógeno sintasa cinasa sobre su capacidad para inducir lt cd4+ reguladores

  2014cites this paper
• Regulatory T cell proliferative potential is impaired in human autoimmune disease

  2013cites this paper
• A Mathematical Model of Immune Activation with a Unified Self-Nonself Concept

  2013cites this paper
• cells promote experimental transplantation tolerance specific CD4+CD25+ regulatory T - expanded donor alloantigen - In vitro

  2013cites this paper
• The role of PPARγ in myeloid cells in experimental autoimmune encephalomyelitis

  2013cites this paper
• Investigation of the activation of tumour-specific immune responses by gene therapy strategies using a model tumour antigen

  2012cites this paper
• Differences in phosphorylation patterns of intracellular signaling proteins in T cells from kidney transplant patients with different outcomes

  2012cites this paper
• EncephalomyelitisMice Resistant to Autoimmune Immunoregulatory Phenotype and Renders Kv1.3 Deletion Biases T Cells toward an

  2012cites this paper
• Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials

  2012cites this paper
• In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.

  2012cites this paper
• Tolerance-Inducing Immunosuppressive Strategies in Clinical Transplantation

  2012cites this paper
• Vaccines for lung cancer

  2012cites this paper
• In vivo imaging of regulatory T cell mediated transplant tolerance

  2012cites this paper
• 122 The Immune System: Development and the Immune Response

  2012cites this paper
• This information is current as Encephalomyelitis Mice Resistant to Autoimmune Immunoregulatory Phenotype and Renders Kv 1 . 3 Deletion Biases T Cells toward an Chandy

  2012cites this paper
• Tolerogenic dendritic cells and their potential applications

  2011cites this paper
• Lung Cancer Vaccines

  2011cites this paper
• Functional Pathway Analysis for Understanding Immunologic Signature of Rejection: Current Approaches and Outstanding Challenges

  2011cites this paper
• Reduced levels of both circulating CD4+CD25+CD127low/neg and CD4+CD8neg invariant natural killer regulatory T cells in stable heart transplant recipients

  2011cites this paper
• Biomarkers to discern transplantation tolerance after allogeneic hematopoietic cell transplantation.

  2010cites this paper
• Immunological tolerance in patient with autosomal dominant polycystic kidney disease after renal transplantation

  2010cites this paper
• Novel fusion protein-expressing lentiviral vectors ameliorate collagen induced arthritis

  2010cites this paper
• Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality.

  2010cites this paper
• The effect of Malononitrilamides (FK778) on phenotypic properties of human peripheral dendritic cells.

  2009cites this paper
• Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.

  2009cites this paper
• Regulatory T Cells

  2009cites this paper
• Dendritic cell-based therapy in Type 1 diabetes mellitus

  2009cites this paper
• Regulation of Rat and Human T-Cell Immune Response by Pharmacologically Modified Dendritic Cells

  2009cites this paper
• Microarrays: monitoring for transplant tolerance and mechanistic insights.

  2008cites this paper
• The highway code of T cell trafficking

  2008cites this paper
• Immunotherapy for Lung Cancer

  2008cites this paper
• Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.

  2008cites this paper
• Immunomodulation and Allogeneic Blood Transfusion

  2008cites this paper
• Analysis of Myelin-Reactive T Lymphocyte Function in Models of Multiple Sclerosis

  2008cites this paper
• A complementary role for the tetraspanins CD37 and Tssc6 in the immune system

  2008cites this paper
• Transplantation Tolerance: From Bench to Bedside

  2008cites this paper
• Vaccination with a neural‐derived peptide plus administration of glutathione improves the performance of paraplegic rats

  2007cites this paper
• The Ubiquitin E3 Ligase Cbl-b in T Cells Tolerance and Tumor Immunity

  2007cites this paper
• Distinctly Different Sensitivity in the Induction and Reversal of Anergy of Th1 and Th2 Cells

  2007cites this paper
• In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.

  2007cites this paper
• Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus

  2007cites this paper
• Immunological Tolerance in Allo- and Xenografts

  2007cites this paper
• From current immunosuppressive strategies to clinical tolerance of allografts

  2007cites this paper
• Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.

  2007cites this paper
• Specific alloantigen self-control by regulatory T cells in organ transplantation: a review.

  2007cites this paper
• Maturation‐Resistant Dendritic Cells Induce Hyporesponsiveness in Alloreactive CD45RA+ and CD45RO+ T‐Cell Populations

  2006cites this paper
• Regulatory dendritic cell therapy in organ transplantation

  2006cites this paper
• How can we measure immunologic tolerance in humans?

  2006cites this paper
• Antigen-based prediction and prevention of type 1 diabetes.

  2006cites this paper
• MANIPULATION OF DENDRITIC CELL MIGRATION AND FUNCTION IN RELATION TO ALLOIMMUNE REACTIVITY AND TRANSPLANT OUTCOME

  2006cites this paper
• Pediatric Unrelated Donor Stem-Cell Transplantation

  2006cites this paper
• Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease?

  2006cites this paper
• Coculture of Th cells with interleukin (IL)-7 in the absence of antigenic stimuli induced T-cell anergy reversed by IL-15.

  2005cites this paper
• Transgenic Ly-49A Inhibits Antigen-Driven T Cell Activation and Delays Diabetes1

  2005cites this paper
• oculture of Th Cells With Interleukin IL )-7 in the Absence of Antigenic timuli Induced T-Cell Anergy eversed by IL-15 u

  2005cites this paper
• The impact of multiple T cell-APC encounters and the role of anergy

  2005cites this paper
• Donor specific hyporesponsiveness in renal transplant recipients

  2005cites this paper
• Regulation of immune response by Plasmodium‐infected red blood cells

  2005cites this paper
• T Cell Activation and Delays Diabetes Transgenic Ly-49A Inhibits Antigen-Driven

  2005cites this paper
• Transgenic Ly-49 A Inhibits Antigen-Driven T Cell Activation and Delays Diabetes 1

  2005cites this paper
• Tolerant T cells display impaired trafficking ability

  2005cites this paper
• Induction by Anti-CD3 Antibodies Naive T Cells Are Resistant to Anergy

  2004cites this paper
• Développement d'un protocole d'induction de tolérance immunologique applicable à la transplantation de myoblastes comme traitement de la dystrophie musculaire de Duchenne

  2004influential citation
• Naive T Cells Are Resistant to Anergy Induction by Anti-CD3 Antibodies1

  2004cites this paper
• The role of LCPTP in T cell signalling and activation.

  2004cites this paper